For patients C and D, in contrast, HR1–HR2 recombinant viruses showed a trend to increase, likely mapping determinants that account for gains in infectivity to HR1–HR2.
← all excerpts
Impact of the HIV-1 env genetic context outside HR1-HR2 on resistance to the fusion inhibitor enfuvirtide and viral infectivity in clinical isolates.
1
—
—